Axia Partners advises MMS LLC in the licensing of its ONCOSCAN Breast Cancer Detection technology to WaveSCAN.
January 20, 2003
For Immediate Release

Ayer, Mass., MMS LLC (MMS), is pleased to announce that it executed an agreement with WaveSCAN, Inc. of Seattle, Washington to provide an exclusive license of its novel ONCOCAN breast cancer detection technology. Axia Advisors acted as the exclusive financial advisor to MMS.

About Axia Partners
Axia Partners (www.axia-partners.com) is a private equity investment and advisory firm that is dedicated to increasing the equity value of our portfolio companies and clients through active participation that leverages the operational experience and in-depth market knowledge of our General Partners. Axia operates as both a private equity investment firm through Axia Capital and as financial advisors through Axia Advisors. Axia is unique in that we focus on these small to midsize transactions in the markets where we have demonstrated, real-world experience.